title: Correction of the soft tissue pollybeak using triamcinolone injection.
abstract: OBJECTIVE
  To describe the technique for correction of the soft tissue pollybeak deformity using intralesional injection of triamcinolone acetonide.
  
  
  METHODS
  We discuss our philosophy, regimen, and technique for treatment of the soft tissue pollybeak using triamcinolone injection. We include results from a series of 173 patients who underwent rhinoplasty performed by one of us (N.J.P.).
  
  
  RESULTS
  Triamcinolone was injected at 1 week after surgery in 127 patients (73%). A second injection was performed in 92 (72%) of the 127 patients at 4 weeks after surgery. One hundred eight (85%) of the 127 patients had an acceptable result, as judged by the surgeon, with good supratip definition. Nineteen (15%) of the 127 patients had a less than optimal result, with residual supratip fullness, as judged by the surgeon. There were no complications caused by triamcinolone injection.
  
  
  CONCLUSIONS
  Because revision surgery is difficult and may be associated with complications, intralesional triamcinolone injection is the first-line treatment for the soft tissue pollybeak deformities caused by subdermal scarring. Should intralesional steroid injection fail to satisfactorily treat the deformity, revision rhinoplasty can subsequently be performed.
authors.affiliation: Facial Plastic Surgery Associates, 6655 Travis St, Suite 900, Houston, TX 77030-1336, USA. rkridel@todaysface.com
authors.forename: Matthew M
authors.initials: MM
authors.lastname: Hanasono
authors.forename: Russell W H
authors.initials: RW
authors.lastname: Kridel
authors.forename: Norman J
authors.initials: NJ
authors.lastname: Pastorek
authors.forename: Mark J
authors.initials: MJ
authors.lastname: Glasgold
authors.forename: R James
authors.initials: RJ
authors.lastname: Koch
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D015552:Injections, Intralesional; D007279:Injections, Subcutaneous; D008297:Male; D008875:Middle Aged; D009667:Nose Deformities, Acquired / Q000209:etiology / Q000628:therapy*; D012086:Reoperation; D012189:Retrospective Studies; D012225:Rhinoplasty / Q000009:adverse effects*; D014222:Triamcinolone Acetonide / Q000008:administration & dosage*
chemical_list: D005938:Glucocorticoids; D014222:Triamcinolone Acetonide